Inventor · Dußlingen, DE

Patrick BAUMHOF

20Patents
13h-index
20Co-inventors
77Inventor score

Filing activity: Jun 22, 2007 → Aug 29, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8968746B2 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation Emerging Cross-Sectional Technologies 59 Active
US8703906B2 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids Human Necessities 57 Active
US10293058B2 RNA containing composition for treatment of tumor diseases Emerging Cross-Sectional Technologies 41 Active
US9907862B2 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids Human Necessities 29 Active
US10799602B2 Method for increasing expression of RNA-encoded proteins Emerging Cross-Sectional Technologies 29 Active
US10918740B2 RNA containing composition for treatment of tumor diseases Emerging Cross-Sectional Technologies 29 Active
US9421255B2 Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates Human Necessities 25 Active
US10869935B2 RNA containing composition for treatment of tumor diseases Emerging Cross-Sectional Technologies 23 Active
US10751424B2 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids Human Necessities 23 Active
US9314535B2 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids Human Necessities 23 Active
US10293060B2 Method for increasing expression of RNA-encoded proteins Emerging Cross-Sectional Technologies 23 Active
US10111967B2 Complexes of RNA and cationic peptides for transfection and for immunostimulation Human Necessities 22 Active
US10568958B2 Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates Human Necessities 22 Active
US11478552B2 Hybrid carriers for nucleic acid cargo Human Necessities 9 Active
US8460941B2 Methods and kit for isolating nucleic acids Emerging Cross-Sectional Technologies 6 Active
US8206990B2 Methods and kit for isolating nucleic acids Emerging Cross-Sectional Technologies 6 Active
US11690910B2 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen Emerging Cross-Sectional Technologies 4 Active
US8435774B2 Enhancing reactivation of thermostable reversibly inactivated enzymes Physics 1 Active
US11931406B2 Flavivirus vaccine Emerging Cross-Sectional Technologies 0 Active
US8728786B2 Enhancing reactivation of thermostable reversibly inactivated enzymes Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.